The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Roll on 2022 then;A group Low loss of £225k, over 12 years in the making and still cannot "turn a profit"
Talks with DSM, who knows where that will end ? All good as far as I can see .
I will continue to add as and when I can. Wonder how the markets will react
Best results so far. As we thought bi-Heath is going for an extra unit/Heath claim. So first half 2022 is submission date. Revenues up 45% though we are still at a loss. I am sure IF will get a good new deal with DSM
It will be nice to get anything after 8 months
RNS's from PXS are like London buses........
Think with such a significant report being issued it warrants an rns from the company. You never know we might even improve sales.
No, the purpose of this RNS is to provide the preliminary results. Any significant information other than the results would likely be in a separate RNS.
By leaving any kind of rns until the last moment, states that it would not be any significant new information ,same old story
It's an important point, patents are crucial, and it seems that more studies produce further areas to be patented.
Yes agree. We have been getting loads of patents done over the last 2 years. All these will help in the eventual buy out
The usual disconnection between the share holders and the board . Maybe the board are working so hard that they carn't find the time to engage.
pumpky
I'm more interested in the patent situation......no major would be on board without the patents all tied up.
W$
We have known the PR has been useless for many years;Black or red ?:Will Blue cap be approved ? Dsm failed to get a major on board:Let's hope the Chinese can do it
Why would anyone buy? Company makes no presentations, does not provide any progress or updates and the CEO is more or less invisible. I think the market has assessed Provexis pretty accurately and until the PR improves, the doldrums will continue IMO.
Yes agree. Just topped up abit a small amount. Seems the MMS don't think the update will be spectacular. Surprised people not buying at these prices. Let's hope for a good update on bi-health (if they can)
The most likely day for your RNS is Thursday.
This RNS (preliminary results) will more than likely confirm the details of the AGM .
The most likely day for your RNS is Thursday.
This RNS (preliminary results) will more than likely confirm the details of the AGM .
And????
The question are they going to release some kind of Rns in September ,or October, they said the Agm is going to be in September but no announcement has bben made about any date ,when the Agm is going to happen
Good news ,now lets see some proactive behaviour by Pxs,how about issuing an RNS !
Hi gixer,
You are our PXS hero like Thoth2 is SAR board. Many thanks for your wonderful thought. Hope not too long to wait till we get the blue hat approval and then a bidding war between DSM and BY Health. In that case it will be worth for this marathon wait.
Should help us/bi-health get blue hat then booooooom
All good news:Just need to sell it now
Alf
good point. I also note the Prof and BH are there
Acknowledgments
We thank By-Health Co., Ltd. for providing Fruitflow in the present study.
Reviewed by:
Wei Cui, Ningbo University, China
Asim K. Duttaroy, University of Oslo, Norway